Home » US regulator rejects cancer drug invented in China in blow to Beijing’s biotech sector

US regulator rejects cancer drug invented in China in blow to Beijing’s biotech sector

Httpsd1e00ek4ebabms cloudfront netproduction008a8ca0 a3cc 4297 a239 35101d9d398d

This post was originally published on this site.

Summit’s ivonescimab was seen as a test case for whether the country’s medicine could pass scrutiny in the US